Funder
NIH
European Union's Horizon 2020 research and innovation program
Gipuzkoako Foru Aldundia
Spanish Ministry of Economy and Competitiveness
Alzheimer's Disease Neuroimaging Initiative
National Institutes of Health
DOD
ADNI
Department of Defense
National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering
AbbVie
Alzheimer's Association
Alzheimer's Drug Discovery Foundation
Araclon Biotech
BioClinica, Inc.
Biogen
Bristol-Myers Squibb Company
CereSpir, Inc.
Eisai Inc.
Elan Pharmaceuticals, Inc.
Eli Lilly and Company
EuroImmun
F. Hoffmann-La Roche Ltd
Genentech, Inc.
Fujirebio
GE Healthcare
IXICO Ltd.
Janssen Alzheimer Immunotherapy Research & Development, LLC.
Johnson & Johnson Pharmaceutical Research & Development LLC.
Lumosity
Lundbeck
Merck & Co., Inc.
Meso Scale Diagnostics, LLC.
NeuroRx Research
Neurotrack Technologies
Novartis Pharmaceuticals Corporation
Pfizer Inc.
Piramal Imaging
Servier
Takeda Pharmaceutical Company
Transition Therapeutics
Canadian Institutes of Health Research
Subject
Cognitive Neuroscience,Neurology
Reference82 articles.
1. Histology-derived volumetric annotation of the human hippocampal subfields in postmortem MRI;Adler;NeuroImage,2014
2. Multipoint quantitative-trait linkage analysis in general pedigrees;Almasy;Am. J. Hum. Genet.,1998
3. Robust variance-components approach for assessing genetic linkage in pedigrees;Amos;Am. J. Hum. Genet.,1994
4. The hippocampus in neurological disease;Bartsch,2012
5. Common variants at 12q14 and 12q24 are associated with hippocampal volume;Bis;Nat. Genet,2012